283 related articles for article (PubMed ID: 11805144)
1. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression.
Walterscheid JP; Ullrich SE; Nghiem DX
J Exp Med; 2002 Jan; 195(2):171-9. PubMed ID: 11805144
[TBL] [Abstract][Full Text] [Related]
2. Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression.
Ramos G; Kazimi N; Nghiem DX; Walterscheid JP; Ullrich SE
Toxicol Appl Pharmacol; 2004 Mar; 195(3):331-8. PubMed ID: 15020195
[TBL] [Abstract][Full Text] [Related]
3. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis.
Pei Y; Barber LA; Murphy RC; Johnson CA; Kelley SW; Dy LC; Fertel RH; Nguyen TM; Williams DA; Travers JB
J Immunol; 1998 Aug; 161(4):1954-61. PubMed ID: 9712066
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis.
Wolf P; Nghiem DX; Walterscheid JP; Byrne S; Matsumura Y; Matsumura Y; Bucana C; Ananthaswamy HN; Ullrich SE
Am J Pathol; 2006 Sep; 169(3):795-805. PubMed ID: 16936256
[TBL] [Abstract][Full Text] [Related]
5. Evidence for involvement of the epidermal platelet-activating factor receptor in ultraviolet-B-radiation-induced interleukin-8 production.
Countryman NB; Pei Y; Yi Q; Spandau DF; Travers JB
J Invest Dermatol; 2000 Aug; 115(2):267-72. PubMed ID: 10951245
[TBL] [Abstract][Full Text] [Related]
6. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10.
Rivas JM; Ullrich SE
J Immunol; 1992 Dec; 149(12):3865-71. PubMed ID: 1460278
[TBL] [Abstract][Full Text] [Related]
7. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression.
Shreedhar V; Giese T; Sung VW; Ullrich SE
J Immunol; 1998 Apr; 160(8):3783-9. PubMed ID: 9558081
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of photocarcinogenesis by platelet-activating factor or serotonin receptor antagonists.
Sreevidya CS; Khaskhely NM; Fukunaga A; Khaskina P; Ullrich SE
Cancer Res; 2008 May; 68(10):3978-84. PubMed ID: 18483284
[TBL] [Abstract][Full Text] [Related]
9. Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage.
Marathe GK; Johnson C; Billings SD; Southall MD; Pei Y; Spandau D; Murphy RC; Zimmerman GA; McIntyre TM; Travers JB
J Biol Chem; 2005 Oct; 280(42):35448-57. PubMed ID: 16115894
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor.
Marrache AM; Gobeil F; Bernier SG; Stankova J; Rola-Pleszczynski M; Choufani S; Bkaily G; Bourdeau A; Sirois MG; Vazquez-Tello A; Fan L; Joyal JS; Filep JG; Varma DR; Ribeiro-Da-Silva A; Chemtob S
J Immunol; 2002 Dec; 169(11):6474-81. PubMed ID: 12444157
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of ultraviolet B radiation-induced tumor necrosis factor production by the epidermal platelet-activating factor receptor.
Dy LC; Pei Y; Travers JB
J Biol Chem; 1999 Sep; 274(38):26917-21. PubMed ID: 10480902
[TBL] [Abstract][Full Text] [Related]
12. Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.
Damiani E; Ullrich SE
Prog Lipid Res; 2016 Jul; 63():14-27. PubMed ID: 27073146
[TBL] [Abstract][Full Text] [Related]
13. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells.
Wang LS; Chow KC; Wu YC
Scand J Gastroenterol; 2002 Apr; 37(4):467-75. PubMed ID: 11989839
[TBL] [Abstract][Full Text] [Related]
14. A role for inflammatory mediators in the induction of immunoregulatory B cells.
Matsumura Y; Byrne SN; Nghiem DX; Miyahara Y; Ullrich SE
J Immunol; 2006 Oct; 177(7):4810-7. PubMed ID: 16982922
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists.
Sahu RP; Petrache I; Van Demark MJ; Rashid BM; Ocana JA; Tang Y; Yi Q; Turner MJ; Konger RL; Travers JB
J Immunol; 2013 Mar; 190(5):2447-54. PubMed ID: 23355733
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species.
Yao Y; Wolverton JE; Zhang Q; Marathe GK; Al-Hassani M; Konger RL; Travers JB
J Immunol; 2009 Mar; 182(5):2842-8. PubMed ID: 19234179
[TBL] [Abstract][Full Text] [Related]
17. cis-Urocanic acid stimulates primary human keratinocytes independently of serotonin or platelet-activating factor receptors.
Kaneko K; Travers JB; Matsui MS; Young AR; Norval M; Walker SL
J Invest Dermatol; 2009 Nov; 129(11):2567-73. PubMed ID: 19474802
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the immune response to alloantigen by factors released from ultraviolet-irradiated keratinocytes.
Ullrich SE; McIntyre BW; Rivas JM
J Immunol; 1990 Jul; 145(2):489-98. PubMed ID: 2142179
[TBL] [Abstract][Full Text] [Related]
19. Activation of the phospholipase/cyclooxygenase cascade in the rabbit cornea by platelet-activating factor is challenged by PAF receptor antagonists.
Hurst JS; Bazan HE
J Ocul Pharmacol Ther; 1995; 11(3):329-37. PubMed ID: 8590265
[TBL] [Abstract][Full Text] [Related]
20. Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line.
Barber LA; Spandau DF; Rathman SC; Murphy RC; Johnson CA; Kelley SW; Hurwitz SA; Travers JB
J Biol Chem; 1998 Jul; 273(30):18891-7. PubMed ID: 9668065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
